Identification and verification of hybridoma-derived monoclonal antibody variable region sequences using recombinant DNA technology and mass spectrometry
Open Access
- 1 October 2017
- journal article
- research article
- Published by Elsevier in Molecular Immunology
- Vol. 90, 287-294
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Antibody therapeutics – the evolving patent landscapeNew Biotechnology, 2011
- Identification of two aberrant transcripts derived from a hybridoma with amplification of functional immunoglobulin variable genesCellular & Molecular Immunology, 2010
- Development trends for therapeutic antibody fragmentsNature Biotechnology, 2009
- PCR amplification of the functional immunoglobulin heavy chain variable gene from a hybridoma in the presence of two aberrant transcriptsJournal of Immunological Methods, 2008
- A simple and rapid protocol for the sequence determination of functional kappa light chain cDNAs from aberrant-chain-positive murine hybridomasJournal of Immunological Methods, 2004
- Rapid cloning of rearranged immunoglobulin genes from human hybridoma cells using mixed primers and the polymerase chain reactionBiochemical and Biophysical Research Communications, 1989
- Hybridoma fusion cell lines contain an aberrant kappa transcriptMolecular Immunology, 1988
- Regulation of immunoglobulin variable region gene assembly: Development of the primary antibody repertoireBioEssays, 1986
- A better cell line for making hybridomas secreting specific antibodiesNature, 1978
- Continuous cultures of fused cells secreting antibody of predefined specificityNature, 1975